Dr. Celalettin Ustun, MD

Dr. Ustun practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Ustun's NPI, 1013010487, was assigned on September 7, 2006. Dr. Ustun graduated from Ankara University FOM in 1990. Dr. Ustun holds Illinois license 036-147386.

Dr. Ustun's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Ustun's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. The medical group on file is Rush University Internists. Dmand AI also links Dr. Ustun to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ustun practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ustun's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Ustun is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ustun's licenses on file in 5 states: Illinois, Indiana, Minnesota, Georgia and North Carolina.

Dmand AI lists multiple myeloma among the conditions Dr. Ustun treats.

CMS data shows 257 Medicare services from Dr. Ustun across 4 procedure codes in 2024, for 52 Medicare patients. Medicare paid $21,876 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Ustun in 2024. The largest group is 65 to 74, with 33 patients. 71% of them have high blood pressure, and 56% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ustun's median patient age at 68, with 54% women.

In 2024, Dr. Ustun wrote 388 Medicare Part D claims for 25 patients. 75% of them were for generic drugs. CMS names the drug for 204 of them, across 9 drugs with 11 or more claims each, at $1,026,759 in total drug cost. In 2023, CMS named 147 claims across 8 drugs.

Dr. Ustun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 200 papers to Dr. Ustun, published from 2002 to 2025. 2017 was the busiest year, with 24. The most frequent topics are Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute and Transplantation, Homologous. Dr. Ustun has published most often in Bone Marrow Transplant. Dr. Ustun's most frequent co-authors are Daniel J. Weisdorf, MD, Cem Akin, MD and Sunita R. Nathan, MD.

Dmand AI links Dr. Ustun to 1 clinical trial. Conditions studied include Myelodysplastic Syndromes and Leukemia, Myeloid, Acute.

CMS Open Payments shows 166 general payments to Dr. Ustun from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $65,575. It also lists 5 research payments totaling $2,414 in 2019.

Dmand AI lists 1 award for Dr. Ustun, most recently CMS Stage 1 EHR in 2013.

Dr. Ustun graduated from Ankara University FOM in 1990.

Dr. Ustun is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.